Diabetologia
October 17, 2026 · via Europe PMC
Renal tubule-specific Nrf2 deletion ameliorates diabetic kidney disease by attenuating glomerular hypertension and kidney injury in a mouse model of diabetes.
Su K, Zhou J, Pang Y, +11 more, Chan JSD.
AI summary — for doctors, generated from the abstract only
In a mouse model of type 1 diabetes, deleting Nrf2 specifically in renal tubules reduced hyperfiltration and kidney injury, pointing to a role for tubular NRF2 in diabetic kidney disease.
What was studied
Animal study in Akita mice crossed with tubule-specific (Pax8-Cre) Nrf2 knockout, with four male groups (n=8 each) followed to 20 weeks; outcomes included GFR, kidney hypertrophy, tubular injury, glomerular basement membrane thickness, podocyte changes and urinary albumin-creatinine ratio.
Key findings
- GFR, kidney hypertrophy, tubular injury, podocyte loss and albuminuria were increased in Akita Nrf2fl/fl mice and markedly reduced in Akita Nrf2RT KO mice
- Attenuated afferent arteriole vasodilation and efferent arteriole vasoconstriction were seen in the knockout
- SGLT2 and angiotensinogen expression in proximal tubules were downregulated in the knockout
- An A1 adenosine receptor inhibitor increased GFR and fractional glucose excretion in knockout mice, suggesting adenosine signalling contributes
Clinical relevance
Highlights tubular NRF2 and tubuloglomerular feedback as possible therapeutic targets, but this is far from clinical application.
Who should care
Limitations
Mouse model of type 1 diabetes, males only, small groups (n=8); mechanism is suggested rather than proven; human relevance is untested.
Preclinical evidence that tubular NRF2 promotes diabetic kidney injury via renal haemodynamics, SGLT2 and angiotensinogen.
This is an AI-generated summary of the published abstract, not a clinical recommendation. It may not reflect the full text or subsequent updates — verify against the original source before acting on it.
Abstract
We previously reported that expression of nuclear factor erythroid 2-related factor 2 (NRF2) is upregulated in the renal tubules of humans with diabetes and in mouse models of diabetes. We hypothesised that Nrf2 deletion would ameliorate renal hyperfiltration and kidney injury in Akita mice (a model of type 1 diabetes). Akita Nrf2RT knockout (KO) mice were generated by cross-breeding tubule-specific (Pax8)-Cre mice with Akita Nrf2 floxed mice on a C57BL/6 background. Male non-diabetic control mice (Nrf2fl/fl), Nrf2RT KO mice, Akita Nrf2fl/fl mice and Akita Nrf2RT KO mice were studied up to the age of 20 weeks (n=8 per group). The glomerular filtration rate (GFR), kidney hypertrophy, tubular injury score, glomerular basement membrane thickness, podocyte loss and foot process effacement and urinary albumin-creatinine ratio were significantly increased in Akita Nrf2fl/fl mice and were markedly reduced in Akita Nrf2RT KO mice compared with the corresponding control mice. Attenuation of afferent arteriole vasodilation and efferent arteriole vasoconstriction was observed in Akita Nrf2RT KO mice compared with Akita Nrf2fl/fl mice. Furthermore, downregulation of sodium-glucose co-transporter 2 (SGLT2) and angiotensinogen expression in renal proximal tubules was observed in Akita Nrf2RT KO mice compared with Akita Nrf2fl/fl mice. Treatment of Akita Nrf2RT KO mice with a selective A1 adenosine receptor inhibitor increased GFR and fractional excretion of glucose, suggesting that enhanced adenosine signalling may contribute to the altered renal haemodynamics through tubuloglomerular feedback and reduced glomerular injury associated with RT-specific Nrf2 deletion. These findings suggest that tubular NRF2 plays an important role in the progression of diabetic kidney disease in Akita mice through modulation of the GFR and expression of SGLT2 and angiotensinogen in renal proximal tubules and tubuloglomerular feedback.
DOI
10.1007/s00125-026-06897-x
PMID
42892652
Research metadata (titles, abstracts, authors, publication dates) is sourced from Europe PMC, which aggregates content from PubMed/MEDLINE, PubMed Central, and other providers under the U.S. National Library of Medicine (NLM/NCBI). NLM does not claim copyright on abstracts; the original journal publishers or authors may hold rights to the full articles. AI-generated summaries are derived only from the abstract, never the full text, and are always labeled as AI-generated.
Want more like this?
Browse more from the feed. A free account unlocks the full feed, saving and communities.
Back to the research feed